Sep 09, 2022 / 04:30PM GMT
Clayton Robertson - Immunocore Holdings PLC - Head of IR
(audio already in progress) to discuss the Phase 1 data from Immunocore's PRAME program. Before I begin, before we begin, I'd like to read some forward-looking statements.
During today's presentation, we'll be making certain forward-looking statements, including about development activities, business strategy, and the timing and impact of future events. Actual results could differ materially from those projected by these statements, which are based on management's views as of today and subject to risks and uncertainties, including those noted on most recent Form 20-F and in the 6-K we filed with the SEC. You're cautioned not to place undue reliance on these statements Immunocore disclaims any obligation to update them. We will also discuss non-IFRS measures in today's presentation, which is reconciled to the comparable IFRS measure in today's slides.
I'm now pleased to introduce our CEO, Dr. Bahija Jallal.
Bahija Jallal - Immunocore Holdings PLC - CEO
Thank you, Clay, and good evening,
Immunocore Holdings PLC PRAME Investor and Analyst Event AT ESMO 2022 Transcript
Sep 09, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers